Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
OncoAlert and ecancer ASCO roundup - Day 1
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer ASCO roundup - Day 1 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Jun 2021
Clinical trials participation is directly influenced by the information received...
Dr Daniel Vorobiof - Belong.Life, New York, USA
Clinical trials participation is directly influenced by the information received by cancer patients and caregivers ( Dr Daniel Vorobiof - Belong.Life, New York, USA )
4 Jun 2021
European Cancer Organisation: Time To Act
Professor Mark Lawler - Queens University Belfast, Belfast, UK
European Cancer Organisation: Time To Act ( Professor Mark Lawler - Queens University Belfast, Belfast, UK )
19 May 2021
Women's cancers in the Democratic Republic of Congo
Prof Richard Sullivan - Kings College London, London, UK
Women's cancers in the Democratic Republic of Congo ( Prof Richard Sullivan - Kings College London, London, UK )
12 May 2021
Rare inherited pathogenic germline variants observed in sporadic paediatric neur...
Dr Emily Blauel - Children’s Hospital of Philadelphia, Philadelphia, USA
Rare inherited pathogenic germline variants observed in sporadic paediatric neuroblastoma cases ( Dr Emily Blauel - Children’s Hospital of Philadelphia, Philadelphia, USA )
11 May 2021
OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
7 May 2021
Anti-tumour activity and tolerability of RMC-4630 as a single agent in patients ...
Prof Ravi Salgia - City of Hope, Duarte, USA
Anti-tumour activity and tolerability of RMC-4630 as a single agent in patients with RAS-addicted solid cancers ( Prof Ravi Salgia - City of Hope, Duarte, USA )
26 Apr 2021
Mechanisms of acquired resistance to KRAS G12C inhibition in cancer
Dr Mark Awad - Dana-Farber Cancer Institute, Boston, USA
Mechanisms of acquired resistance to KRAS G12C inhibition in cancer ( Dr Mark Awad - Dana-Farber Cancer Institute, Boston, USA )
26 Apr 2021
Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small ...
Dr Erminia Massarelli - City of Hope, Duarte, USA
Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small cell lung cancer ( Dr Erminia Massarelli - City of Hope, Duarte, USA )
1 Apr 2021
Highlights from AORTIC Cancer Genomics Conference 2021
Dr Hannah Ayettey - National Radiotherapy Oncology and Nuclear Medicine Center, ...
Highlights from AORTIC Cancer Genomics Conference 2021 ( Dr Hannah Ayettey - National Radiotherapy Oncology and Nuclear Medicine Center, Accra, Ghana )
30 Mar 2021
Incorporating KRAS as a novel biomarker: Challenges and opportunities
Prof Ales Ryska - Charles University, Prague, Czech Republic
Incorporating KRAS as a novel biomarker: Challenges and opportunities ( Prof Ales Ryska - Charles University, Prague, Czech Republic )
29 Mar 2021
Real world data and diagnostics in patients with NSCLC with EGFR exon 20 inserti...
Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passa...
Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions ( Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passaro )
29 Mar 2021